Published in Healthcare Finance, Tax and Law Weekly, October 27th, 2004
Neumune is an investigational immune regulating hormone being developed by Hollis-Eden as a treatment for acute radiation injury pursuant to the U.S. Food and Drug Administration (FDA) "animal rule" for countermeasures to weapons of mass destruction.
Under the FDA animal rule, because it would be unethical to conduct efficacy studies in humans, results in animals are used as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly